These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intraocular penetration of pyruvate following its topical administration in mice. Hegde KR; Kovtun S; Varma SD Mol Cell Biochem; 2010 May; 338(1-2):87-90. PubMed ID: 20012886 [TBL] [Abstract][Full Text] [Related]
8. Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo. Varma SD; Ramachandran S; Devamanoharan PS; Morris SM; Ali AH Curr Eye Res; 1995 Aug; 14(8):643-9. PubMed ID: 8529399 [TBL] [Abstract][Full Text] [Related]
9. Preventive effect of topical vitamin E-containing liposome instillation on the progression of galactose cataract. Comparison between 5-week- and 12-week-old rats fed a 25% galactose diet. Ohta Y; Yamasaki T; Niwa T; Majima Y; Ishiguro I Exp Eye Res; 1999 Jun; 68(6):747-55. PubMed ID: 10375438 [TBL] [Abstract][Full Text] [Related]
10. Induction of ultraviolet cataracts in vitro: prevention by pyruvate. Hegde KR; Kovtun S; Varma SD J Ocul Pharmacol Ther; 2007 Oct; 23(5):492-502. PubMed ID: 17900232 [TBL] [Abstract][Full Text] [Related]
11. Possibility of topical antioxidant treatment of cataracts: corneal penetration of pyruvate in humans. Chandra P; Hegde KR; Varma SD Ophthalmologica; 2009; 223(2):136-8. PubMed ID: 19088495 [TBL] [Abstract][Full Text] [Related]
12. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts. Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats. Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367 [TBL] [Abstract][Full Text] [Related]
14. Cataract development in 12-month-old rats fed a 25% galactose diet and its relation to osmotic stress and oxidative damage. Ohta Y; Yamasaki T; Niwa T; Goto H; Majima Y; Ishiguro I Ophthalmic Res; 1999; 31(5):321-31. PubMed ID: 10420116 [TBL] [Abstract][Full Text] [Related]
15. Galactose metabolism in male and female rats. II. Eye-ball differences. Kechrid RM; Adrian J; Poiffait A Int J Vitam Nutr Res; 1986; 56(3):269-73. PubMed ID: 3781751 [TBL] [Abstract][Full Text] [Related]
16. Ophthalmoscopic and morphogenetic changes in rat lens induced by galactose: attenuation by pyruvate. Kalakonda S; Hegde KR; Varma SD Diabetes Obes Metab; 2004 May; 6(3):216-22. PubMed ID: 15056130 [TBL] [Abstract][Full Text] [Related]
17. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention. Babizhayev MA Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259 [TBL] [Abstract][Full Text] [Related]
18. Attenuation and delay of diabetic cataracts by antioxidants: effectiveness of pyruvate after onset of cataract. Varma SD; Hegde KR; Kovtun S Ophthalmologica; 2005; 219(5):309-15. PubMed ID: 16123559 [TBL] [Abstract][Full Text] [Related]
19. Changes of some biochemical parameters of the lens in galactose-treated weaned rats with and without vitamin E therapy. Libondi T; Menzione M; Iuliano G; Della Corte M; Latte F; Auricchio G Ophthalmic Res; 1985; 17(1):42-8. PubMed ID: 3920597 [TBL] [Abstract][Full Text] [Related]
20. Galactitol accumulation and irreversible lens opacities in galactosemic rats. Simard-Duquesne N; Dvornik D Invest Ophthalmol; 1973 Jan; 12(1):82-3. PubMed ID: 4691951 [No Abstract] [Full Text] [Related] [Next] [New Search]